Source: DGNews | Posted 8 years ago
FDA Issues Approvable Letter for Migraine Prophylaxis Indication for Topamax (Topiramate)
Tags:
RARITAN, NJ -- November 18, 2003 -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), a Johnson & Johnson company, announced today that the U.S. Food and Drug Administration (FDA) has issued an approvable letter related to its supplemental New Drug Application for the use of Topamax
Comments